Circular antisense oligonucleotides inhibit growth of chronic myeloid leukemia cells

Molecular Medicine

Volumn 5, Issue 10, 1999, Pages 693-700

  Rowley, P T ^a   Kosciolek, B A ^a   Kool, E T ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BCR ABL PROTEIN;

ARTICLE; BASE MISPAIRING; BINDING AFFINITY; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG MECHANISM; GENE EXPRESSION; GENE SEQUENCE; GENE THERAPY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; PRIORITY JOURNAL; RNA BINDING; WESTERN BLOTTING;

EID: 0033276594     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401988     Document Type: Article

References (32)

1. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining
2. bcr/abl expression in K562 cells by electro-poration with an antisense oligonucleotide
3. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides
4. Capping of bcr-abl antisense oligonucleotides enhances antiproliferative activity against chronic myeloid leukemia cell lines
5. Modified deoxyoligonucleotides stable to exonuclease degradation in serum
6. The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells
7. BCR-ABL antisense purging in chronic myeloid leukaemia
8. Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells
9. Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines
10. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173
11. Sequence specificity on the growth suppression and induction of apoptosis of chronic myeloid leukemia cells by BCR-ABL antisense oligodeoxynucleoside phosphorothioates
12. BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism
13. Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides
14. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular Bcr-Abl protein levels
15. bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure
16. Inhibition of protein-tyrosine kinase activity in intact cells by the aptameric action of oligodeoxynucleotides
17. Antisense oligodeoxynucleotides as therapeutic agents for chronic myelogenous leukemia
18. Molecular recognition by circular oligonucleotides. Strong binding of single-stranded DNA and RNA
19. Solvent, pH, and ionic effects on the binding of single-stranded DNA by circular oligodeoxynucleotides
20. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
21. 1-positive human cell line (BV173)
22. Deoxynucleoside phosphoramidites - A new class of key intermediates for deoxypolynucleotide synthesis
23. A chemical 5′-phosphorylation of oligodeoxyribonucleotides that can be monitored by trityl cation release
24. Optical properties of nucleic acids, absorption, and circular dichroism spectra
25. Molecular recognition by circular oligonucleotides. Increasing the selectivity of DNA binding
26. Structural effects in the recognition of DNA by circular oligonucleotides
27. Circular RNA oligonucleotides. Synthesis, nucleic acid binding properties, and a comparison with circular DNAs
28. Convergent DNA synthesis: A non-enzymatic dimerization approach to circular oligodeoxynucleotides
29. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias
30. Circular oligonucleotides as potential modulators of gene expression
31. Relative stabilities of triple helices composed of combinations of DNA, RNA and 2′-O-methyl-RNA backbones: Chimeric circular oligonucleotides as probes